Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

NCT05838092 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: allo-APZ2-OTS
DRUG: Placebo

Sponsor

RHEACELL GmbH & Co. KG